SK Bioscience Licenses CDC Rotavirus Vaccine Technology to Advance Global Immunisation Efforts
SK Bioscience Licenses CDC Rotavirus Vaccine Technology to Advance Global Immunisation Efforts
Publish Date: 2026-06-10 14:32:00
Source Domain: biopharmaapac.com
Backed by the RIGHT Foundation, SK Bioscience will develop an injectable rotavirus vaccine aimed at improving protection and expanding access for children in low- and middle-income countries.
| SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention |
- SK bioscience is jointly investing with the RIGHT Foundation to drive process development that enhances both efficacy and productivity
- “We are committed to improving public health through continuous innovation and global partnership.”
SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that, after entering into a license agreement with the U.S. Centers for Disease Control and Prevention (CDC), it has initiated process development for an injectable rotavirus vaccine candidate. Following successful process development, the company plans to advance the vaccine through subsequent clinical trials, regulatory approval, and ultimately, commercialization.
View of SK Bioscience’s Songdo headquarters.
Through the license agreement with CDC, SK bioscience has become the first Korean company to receive vaccine technology from the CDC. Previously, the CDC developed the injectable inactivated rotavirus vaccine technology and sponsored a Phase I clinical trial. SK bioscience plans to rapidly implement this technology domestically, establishing a production process that simultaneously enhances vaccine efficacy and reduces costs, while advancing through clinical development and ultimately commercialization.
The project is further supported by the Research Investment for Global Health Technology Foundation (the RIGHT Foundation). SK bioscience signed a research and development funding agreement with the RIGHT Foundation for the rotavirus vaccine process in June 2025.
The RIGHT Foundation is the first non-profit international public-private partnership funding…
